These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 24978101

  • 1. Bioavailability of a generic of the immunosuppressive agent mycophenolate mofetil in pediatric patients.
    González-Ramírez R, González-Bañuelos J, Villa Mde L, Jiménez B, García-Roca P, Cruz-Antonio L, Castañeda-Hernández G, Medeiros M.
    Pediatr Transplant; 2014 Sep; 18(6):568-74. PubMed ID: 24978101
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil 500-mg tablet under fasting conditions: single-dose, randomized-sequence, open-label, four-way replicate crossover, bioequivalence study in healthy subjects.
    Almeida S, Filipe A, Neves R, Spínola AC, Tanguay M, Ortuño J, Farré A, Torns A.
    Clin Ther; 2010 Mar; 32(3):556-74. PubMed ID: 20399993
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Single-dose, two-way crossover, bioequivalence study of Mycophenolate mofetil 500 mg tablet under fasting conditions in healthy male subjects.
    Patel S, Chauhan V, Mandal J, Shah S, Patel K, Saptarshi D, Maheshwari K, Jha PK, Kale P, Patel K, Mathew P.
    Clin Ther; 2011 Mar; 33(3):378-90. PubMed ID: 21600390
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pilot study on the efficacy and safety of generic mycophenolate mofetil (Mycept) compared with Cellcept among incident low-risk primary kidney transplant recipients.
    Danguilan RA, Lamban AB, Luna CA, Bacinillo M, Momongan MI.
    Transplant Proc; 2014 Mar; 46(2):415-7. PubMed ID: 24655977
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome.
    Videla C, Godoy C.
    Transplant Proc; 2007 Apr; 39(3):602-5. PubMed ID: 17445555
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of dissolution properties of 2 enteric-coated formulations containing mycophenolate sodium: Myfortic vs Femulan.
    Esquivel A, González-Ramírez R, Alberú J, Gracida C, Medeiros M, Castañeda-Hernández G.
    Transplant Proc; 2010 Apr; 42(1):353-6. PubMed ID: 20172348
    [Abstract] [Full Text] [Related]

  • 13. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.
    Hale MD, Nicholls AJ, Bullingham RE, Hené R, Hoitsma A, Squifflet JP, Weimar W, Vanrenterghem Y, Van de Woude FJ, Verpooten GA.
    Clin Pharmacol Ther; 1998 Dec; 64(6):672-83. PubMed ID: 9871432
    [Abstract] [Full Text] [Related]

  • 14. The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.
    Johnson HJ, Swan SK, Heim-Duthoy KL, Nicholls AJ, Tsina I, Tarnowski T.
    Clin Pharmacol Ther; 1998 May; 63(5):512-8. PubMed ID: 9630824
    [Abstract] [Full Text] [Related]

  • 15. Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteers.
    Rupprecht K, Schmidt C, Raspé A, Schweda F, Shipkova M, Fischer W, Bucher M, Kees F, Faerber L.
    J Clin Pharmacol; 2009 Oct; 49(10):1196-201. PubMed ID: 19783713
    [Abstract] [Full Text] [Related]

  • 16. Generics in transplantation medicine: Randomized comparison of innovator and substitution products containing mycophenolate mofetil
.
    Reigner B, Grange S, Bentley D, Banken L, Abt M, Hughes R, Scheubel E, Guentert TW.
    Int J Clin Pharmacol Ther; 2019 Oct; 57(10):506-519. PubMed ID: 31397274
    [Abstract] [Full Text] [Related]

  • 17. Influence of renal graft function on mycophenolic acid pharmacokinetics during the early period after kidney transplant.
    Mohammadpur AH, Nazemian F, Abtahi B, Naghibi M.
    Exp Clin Transplant; 2008 Dec; 6(4):276-81. PubMed ID: 19338489
    [Abstract] [Full Text] [Related]

  • 18. Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?
    Phillips K, Reddy P, Gabardi S.
    J Pharm Pract; 2017 Feb; 30(1):9-16. PubMed ID: 26043743
    [Abstract] [Full Text] [Related]

  • 19. The role of generics in transplantation: TM-MMF versus Cellcept in healthy volunteers.
    Masri MA, Andrysek T, Rizk S, Matha V.
    Transplant Proc; 2004 Feb; 36(1):84-5. PubMed ID: 15013307
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.